세계의 CRISPR 기술 시장 규모는 2023년 34억 달러, 2024년 38억 달러에서 예측 기간 중 14.4%의 CAGR로 추이하며, 2029년말에는 75억 달러 규모로 성장할 것으로 예측됩니다.
용도별로는 의약품 개발 용도 부문이 2024년 19억 달러에서 15.5%의 CAGR로 추이하며, 2029년에는 38억 달러로 성장할 것으로 예측됩니다. 농업 용도 부문이 2024년 10억 달러에서 14.2%의 CAGR로 추이하며, 2029년에는 20억 달러로 성장할 것으로 예측됩니다.
세계의 CRISPR 기술의 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 개요
제2장 시장 개요
유전자 편집
CRISPR
CRISPR 컴포넌트
작용기서
CRISPR 유전자 편집 워크플로우
CRISPR 기술의 이점과 결점
가격 분석
PESTLE 분석
Porter's Five Forces 분석
규제 상황 : 유형별
인간
유전자 드라이브
농업
동물
규제 상황 : 지역별
북미
유럽
아시아태평양
기타 지역
제3장 시장 역학
시장 역학 스냅숏
시장 성장 촉진요인
만성질환 발증률의 상승
유전성 질환의 유병률
정부와 민간 자금
시장 성장 억제요인
대체 기술
시장 기회
신청 건수의 증가
시장이 해결해야 할 과제
복잡하고 진화하는 규제 상황
CRISPR 기반 치료의 고비용성
제4장 신규 기술과 개발
신규 기술
CRISPR 생체내 송달
개량된 Cas 배리언트
AI
임상시험 분석
임상시험 분석(연구 유형별)
임상시험 분석(현황별)
임상시험 분석(단계별)
임상시험
특허 분석
특허(연별)
특허(출원인별)
특허(주요 소유자별)
특허(관할별)
지적재산 분쟁·특허 문제
제5장 시장 세분화 분석
세분화 내역
시장 내역 : 용도별
의약품 개발
농업
진단
기타
시장 내역 : 최종사용자별
바이오테크놀러지·제약 기업
학술·정부 연구기관
CRO
지역적 내역
시장 내역 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
시장 분석
전략 분석
제7장 CRISPR 기술의 지속가능성 : ESG 관점
ESG : 서론
CRISPR 기술의 지속가능성 : ESG 관점
주요 ESG 문제
CRISPR 기술 ESG 퍼포먼스 분석
환경 퍼포먼스
사회적 퍼포먼스
거버넌스 퍼포먼스
BCC에 의한 결론
제8장 부록
조사 방법
참고 문헌
약어
기업 개요
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
KSA
영문 목차
영문목차
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
The global market for CRISPR technology in drug development application is expected to grow from $1.9 billion in 2024 to $3.8 billion by 2029, at a CAGR of 15.5% from 2024 to 2029.
The global market for CRISPR technology in agriculture application is expected to grow from $1.0 billion in 2024 to $2.0 billion by 2029, at a CAGR of 14.2% from 2024 to 2029.
Report Scope
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Includes
32 data tables and 61 additional tables
An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
Discussion of the market potential for CRISPR technology
Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
A discussion on ESG challenges and ESG practices of the industry participants
A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Genome Editing
CRISPR
Introduction
Components of CRISPR
Mechanism of Action
CRISPR Gene Editing Workflow
Advantages and Disadvantages of CRISPR Technology
Pricing Analysis
PESTLE Analysis
Porter's Five Forces Analysis
Regulatory Landscape, by Type
Human
Gene Drives
Agriculture
Animals
Regulatory Landscape, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Rising Incidence of Chronic Diseases
Prevalence of Genetic Disorders
Government and Private Funding
Market Restraints
Alternative Technologies
Market Opportunities
Increase in the Number of Applications
Market Challenges
Complex and Evolving Regulatory Landscape
High Cost of CRISPR-based Therapy
Chapter 4 Emerging Technologies and Developments
Emerging Technologies
In Vivo Delivery of CRISPR
Improved Cas Variants
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Clinical Trials
Patent Analysis
Patents, by Year
Patents, by Top Applicant
Patents, by Top Owner
Patents, by Jurisdiction
Intellectual Property Disputes and Patent Issues
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown, by Application
Drug Development
Agriculture
Diagnostics
Other Applications
Market Breakdown, by End User
Biotech and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Market Analysis
Strategic Analysis
Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
Introduction to ESG
Sustainability in CRISPR Technology: An ESG Perspective
